New oxadiazole and pyrazoline derivatives as anti-proliferative agents targeting EGFR-TK: design, synthesis, biological evaluation and molecular docking study
Abstract Two new series of oxadiazole and pyrazoline derivatives were designed and synthesized as promising EGFR-TK inhibitors. The in vitro antiproliferative activity was studied against three human cancer cell lines; HCT116, HepG-2 and MCF7 using MTT assay. Compound 10c showed the most potent anti...
Main Authors: | Marwa I. Serag, Samar S. Tawfik, Sahar M. I. Badr, Hassan M. Eisa |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2024-03-01
|
Series: | Scientific Reports |
Subjects: | |
Online Access: | https://doi.org/10.1038/s41598-024-55046-0 |
Similar Items
-
Synthesis, anticancer activity and docking studies of pyrazoline and pyrimidine derivatives as potential epidermal growth factor receptor (EGFR) inhibitors
by: Menier Al-Anazi, et al.
Published: (2022-07-01) -
Synthesis and Evaluation of New Pyrazoline Derivatives as Potential Anticancer Agents
by: Muhammed Karabacak, et al.
Published: (2015-10-01) -
Chalcone/1,3,4-Oxadiazole/Benzimidazole hybrids as novel anti-proliferative agents inducing apoptosis and inhibiting EGFR & BRAFV600E
by: Fatma Fouad Hagar, et al.
Published: (2023-09-01) -
Design, Synthesis, and Biological Evaluation of Novel 3-Cyanopyridone/Pyrazoline Hybrids as Potential Apoptotic Antiproliferative Agents Targeting EGFR/BRAF<sup>V600E</sup> Inhibitory Pathways
by: Lamya H. Al-Wahaibi, et al.
Published: (2023-09-01) -
Anticonvulsant evaluation of 2-pyrazolines carrying naphthyl moiety: An insight into synthesis and molecular docking study
by: Birjees Nusrat, et al.